CAPTRUST Financial Advisors
IRON icon

CAPTRUST Financial Advisors’s Disc Medicine IRON Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed – – 5020
2021
Q4 		$0 Buy
+2
New +$196 ﹤0.01% 4836

Other funds holding IRON

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAPTRUST Financial Advisors's IRON Position: Q1 2022 in Review

CAPTRUST Financial Advisors sold out of Disc Medicine (IRON) in Q1 2022, closing a stake of 2 shares.

CAPTRUST Financial Advisors first reported a position in IRON in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 57 funds tracked by Wall St. Rank hold IRON as of Q1 2022.

  • CAPTRUST Financial Advisors reported no remaining Disc Medicine position as of Q1 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2 Disc Medicine shares in Q1 2022.
  • CAPTRUST Financial Advisors first reported a position in Disc Medicine in Q4 2021 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Disc Medicine position peaked at $0 in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.